Found: 71
Select item for more details and to access through your institution.
Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 13, p. 4073, doi. 10.1007/s00259-024-06830-7
- By:
- Publication type:
- Article
Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography.
- Published in:
- Journal of Biomedical Optics, 2013, v. 18, n. 9, p. 1, doi. 10.1117/1.JBO.18.9.096012
- By:
- Publication type:
- Article
Racial Disparities in Clinical Outcomes on Investigator-Initiated Breast Cancer Clinical Trials at an Urban Medical Center.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Advances in Therapeutic Approaches for Triple-Negative Breast Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Durable Clinical Activity to the AKT Inhibitor Ipatasertib in a Heavily Pretreated Patient With an AKT1 E17K Mutant Metastatic Breast Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Some Postmenopausal Women With Early-Stage Breast Cancer on Hormone Therapy Can Forego Chemotherapy.
- Published in:
- Clinical Breast Cancer, 2021, p. 18
- By:
- Publication type:
- Article
Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prospective Study Evaluating Changes in Bone Quality in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Expanding the Criteria for Nipple-Sparing Mastectomy in Patients With Poor Prognostic Features.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Invasive Lobular Breast Carcinoma: Pleomorphic Versus Classical Subtype, Associations and Prognosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer.
- Published in:
- EMBO Molecular Medicine, 2024, v. 16, n. 8, p. 1957, doi. 10.1038/s44321-024-00094-2
- By:
- Publication type:
- Article
Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 208, n. 1, p. 203, doi. 10.1007/s10549-024-07412-9
- By:
- Publication type:
- Article
Correction: Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 207, n. 3, p. 599, doi. 10.1007/s10549-024-07376-w
- By:
- Publication type:
- Article
Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 204, n. 1, p. 49, doi. 10.1007/s10549-023-07172-y
- By:
- Publication type:
- Article
Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 3, p. 49, doi. 10.1007/s10549-023-07172-y
- By:
- Publication type:
- Article
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2− MBC in the real world.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 201, n. 1, p. 105, doi. 10.1007/s10549-023-06993-1
- By:
- Publication type:
- Article
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2− MBC in the real world.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 200, n. 3, p. 105, doi. 10.1007/s10549-023-06993-1
- By:
- Publication type:
- Article
Patient-centered dosing: oncologists' perspectives about treatment-related side effects and individualized dosing for patients with metastatic breast cancer (MBC).
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 196, n. 3, p. 549, doi. 10.1007/s10549-022-06755-5
- By:
- Publication type:
- Article
Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 195, n. 2, p. 127, doi. 10.1007/s10549-022-06602-7
- By:
- Publication type:
- Article
Use of a convolutional neural network-based mammographic evaluation to predict breast cancer recurrence among women with hormone receptor-positive operable breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 194, n. 1, p. 35, doi. 10.1007/s10549-022-06614-3
- By:
- Publication type:
- Article
Utility of Oncotype DX score in clinical management for T1 estrogen receptor positive, HER2 negative, and lymph node negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 192, n. 3, p. 509, doi. 10.1007/s10549-022-06530-6
- By:
- Publication type:
- Article
Diffuse optical tomography breast imaging measurements are modifiable with pre-surgical targeted and endocrine therapies among women with early stage breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 1, p. 297, doi. 10.1007/s10549-021-06320-6
- By:
- Publication type:
- Article
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 1, p. 177, doi. 10.1007/s10549-021-06306-4
- By:
- Publication type:
- Article
Clinical trial data and emerging immunotherapeutic strategies: hormone receptor-positive, HER2− negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 189, n. 1, p. 1, doi. 10.1007/s10549-021-06291-8
- By:
- Publication type:
- Article
Phase II study of propranolol feasibility with neoadjuvant chemotherapy in patients with newly diagnosed breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 2, p. 427, doi. 10.1007/s10549-021-06210-x
- By:
- Publication type:
- Article
Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG).
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 11, doi. 10.1007/s10549-018-4783-1
- By:
- Publication type:
- Article
A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 170, n. 3, p. 547, doi. 10.1007/s10549-018-4770-6
- By:
- Publication type:
- Article
TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241248336
- By:
- Publication type:
- Article
Are we closer to being able to select patients with node-positive hormone receptor-positive breast cancer who can safely omit chemotherapy?
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221084769
- By:
- Publication type:
- Article
Effects of neoadjuvant chemotherapy on the contralateral non-tumor-bearing breast assessed by diffuse optical tomography.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Convolutional Neural Network Using a Breast MRI Tumor Dataset Can Predict Oncotype Dx Recurrence Score.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Toronto Workshop on Late Recurrence in Estrogen Receptor–Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations.
- Published in:
- JNCI Cancer Spectrum, 2019, v. 3, n. 4, p. N.PAG, doi. 10.1093/jncics/pkz050
- By:
- Publication type:
- Article
Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00439-5
- By:
- Publication type:
- Article
If we build it they will come: targeting the immune response to breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0133-7
- By:
- Publication type:
- Article
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0130-x
- By:
- Publication type:
- Article
356 The Effect of Regional Anesthesia on Breast Cancer Recurrence.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
AKT in cancer: new molecular insights and advances in drug development.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 4, p. 943, doi. 10.1111/bcp.13021
- By:
- Publication type:
- Article
Trop-2 as a Therapeutic Target in Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5936, doi. 10.3390/cancers14235936
- By:
- Publication type:
- Article
Advances in SERDs and Other Novel Endocrine Therapies.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 6, p. 294
- By:
- Publication type:
- Article
Obesity’s impact on survival is independent of dose adjustments in neoadjuvant chemotherapy in women with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 168, n. 1, p. 285, doi. 10.1007/s10549-017-4590-0
- By:
- Publication type:
- Article
Obesity and survival in the neoadjuvant breast cancer setting: role of tumor subtype in an ethnically diverse population.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 1, p. 277, doi. 10.1007/s10549-017-4507-y
- By:
- Publication type:
- Article
Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 162, n. 3, p. 533, doi. 10.1007/s10549-017-4150-7
- By:
- Publication type:
- Article
Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 157, n. 3, p. 555, doi. 10.1007/s10549-016-3837-5
- By:
- Publication type:
- Article
Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 156, n. 3, p. 453, doi. 10.1007/s10549-016-3759-2
- By:
- Publication type:
- Article
A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 146, n. 1, p. 145, doi. 10.1007/s10549-014-3008-5
- By:
- Publication type:
- Article